CRKL is well known as a surrogate substrate of BCR-ABL kinase in chronic myeloid leukemia and acute lymphoblastic leukemia [11,27,28], and intensive studies of CRKL in Philadelphia chromosome-positive leukemia have been performed. Here, CRKL is linked to chronic myelogenous leukemia, BCR-ABL1 positive.